LAURA SCHRECKENGOST: Open Payments
NPI 1851764302 · MIDDLETOWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$327 in 13 payments from 7 companies in 2025. Trend: 2023 $669 · 2024 $948 · 2025 $327
Food & beverage: $229Education: $98
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 3 | $135 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $33 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $24 |
| Alkermes, Inc. | 1 | $14 |
Products named: TRINTELLIX, UZEDY, CAPLYTA, REXULTI, Auvelity, VRAYLAR, ARISTADA.
Industry payments across OH — which companies pay providers there.
